Corcept Therapeutics Incorporated CORT

116.10 (2.41) (2.03%) as of 25 Sep
Market cap
$12.9B
P/E
223×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
37.02 37.33 23.46 21.23 22.76 28.43 14.58 20.55 16.05 105.44
P/S ratio
4.75 7.71 5.19 5.36 6.26 8.53 4.51 6.13 12.94 10.01
P/FCF ratio
25.49 26.52 19.78 17.96 13.68 20.03 10.25 13.36 34.03 44.72
P/Operating CF
94.01 86.61 452.52 64.51 46.33 86.09 28.56 71.61 82.76 178.11
P/B ratio
5.58 7.65 4.94 4.29 6.09 5.77 3.73 5.59 10.78 19.67
Price to Tangible BV
5.58 7.65 4.94 4.29 6.09 5.77 3.73 5.59 10.78 19.67
EV/Sales
4.27 7.15 4.43 4.29 5.65 7.29 3.63 5.37 12.47 9.60
EV/EBITDA
78.09 37.89 21.24 14.68 15.54 19.79 9.77 15.32 37.46 75.89
EV/Operating CF
22.87 24.33 16.85 14.33 12.31 16.98 8.16 11.66 32.57 42.45
EV/FCF
22.90 24.60 16.87 14.38 12.35 17.12 8.23 11.69 32.79 42.90
Quick Ratio
2.60 3.11 3.92 6.38 5.28 9.83 7.62 6.31 3.95 2.24
Current Ratio
2.92 3.35 4.39 6.89 5.60 10.08 7.91 6.66 4.20 2.40
Net Debt/EBITDA
(8.83) (2.96) (3.66) (3.67) (1.68) (3.36) (2.39) (2.35) (1.68) (3.58)
Debt/Assets
0.60% 0.73% 0.00% 0.20% 0.12% 0.45% 0.84% 0.00% 0.00% 21.33%
Debt/Equity
0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.35
Asset Turnover
0.91 0.92 0.80 0.80 0.74 0.72 0.85 0.94 1.10 1.35
Operating CF/Net income
1.45 1.42 1.20 1.19 1.49 1.43 1.45 1.53 0.47 2.26
Capex/Depreciation
0.07 0.23 0.02 (0.09) (0.05) (0.55) (0.50) 0.20 (3.49) (1.80)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
14.79% 23.56% 20.92% 23.08% 25.03% 23.70% 29.11% 32.31% 111.15% 27.19%
ROA
11.71% 19.11% 17.51% 20.11% 22.60% 21.55% 26.02% 28.34% 89.27% 13.49%
ROIC
9.98% 28.31% 48.42% 98.71% 50.92% 94.05% 70.69% 80.92% 32.32% 141.16%
Return on Tangible Assets
30.56% 41.90% 29.77% 23.70% 51.16% 24.50% 34.94% 37.35% 135.73% 21.13%
Average Days of Receivables
28.66 29.19 31.12 28.21 27.55 27.02 23.73 25.55 64.64 44.26
Research and Development Expense of Revenue
33.48% 36.57% 38.22% 32.60% 31.11% 32.43% 29.04% 29.95% 25.36% 29.32%
Selling, General and Administrative Expense of Revenue
58.93% 41.53% 38.20% 38.04% 33.43% 29.76% 32.75% 32.35% 39.21% 55.63%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
11.10% 9.09% 10.15% 10.56% 11.73% 9.48% 9.56% 9.45% 8.39% 8.68%
Graham Net Nets
0.08 0.06 0.14 0.19 0.10 0.14 0.19 0.13 0.05 0.05
Graham Number
11.49 14.14 10.65 10.02 7.98 9.69 7.79 5.91 6.54 0.77
Earnings Yield
2.70% 2.68% 4.26% 4.71% 4.39% 3.52% 6.86% 4.87% 6.23% 0.95%
Free Cash Flow Yield
3.92% 3.77% 5.06% 5.57% 7.31% 4.99% 9.76% 7.49% 2.94% 2.24%
Revenue per Share
7.33 6.54 4.66 3.76 3.16 3.07 2.68 2.18 1.40 0.74
Operating CF per Share
1.37 1.92 1.22 1.13 1.45 1.32 1.19 1.00 0.54 0.17
Capex per Share
0.00 (0.02) 0.00 0.00 0.00 (0.01) (0.01) 0.00 0.00 0.00
Free Cash Flow per Share
1.37 1.90 1.22 1.12 1.45 1.31 1.18 1.00 0.53 0.16
Cash per Share
3.58 3.71 3.56 4.04 1.93 3.82 2.41 1.79 0.78 0.47
Shareholders Equity per Share
6.24 6.58 4.89 4.70 3.25 4.53 3.25 2.39 1.68 0.37
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
6.24 6.58 4.89 4.70 3.25 4.53 3.25 2.39 1.68 0.37
Free Cash Flow
141.79 196.12 126.54 119.91 167.42 150.73 135.03 115.37 60.52 18.20
Working Capital
319.38 330.83 354.13 426.76 218.92 431.01 268.52 201.25 94.62 38.32
Capital Expenditures
(0.21) (2.17) (0.14) (0.41) (0.47) (1.24) (1.09) (0.30) (0.42) (0.19)
Net Current Asset Value
296.62 310.64 343.82 417.67 218.51 430.11 266.23 201.01 94.62 38.32
EV/EBIT
72.49 35.23 19.90 15.31 16.61 20.13 9.96 15.06 37.55 76.69
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit Margin
12.89% 20.70% 21.87% 25.20% 30.74% 29.96% 30.73% 30.01% 81.11% 10.01%
Price to Operating Income
80.68 37.98 23.32 19.12 18.40 23.55 12.40 17.22 38.96 79.95
Other line items
Depreciation/Fixed assets
(1.70) (3.57) (34.70) 7.63 8.54 1.34 2.07 (2.27) 0.23 0.53
Cash ROIC
13.67% 18.30% 14.46% 12.81% 27.82% 15.55% 20.76% 23.83% 21.60% 16.90%
Accounts Receivable Turnover
13.39 14.20 13.37 13.70 13.60 15.34 16.34 10.98 8.37 10.11
Accounts Payable Turnover
0.47 0.66 0.44 0.57 0.60 0.62 0.70 0.62 0.65 1.14
Inventory Turnover
1.03 1.08 0.94 0.97 1.07 1.08 1.08 1.12 1.03 1.03
Average Days of Payables
1,137.56 515.74 979.72 811.74 477.45 690.11 499.82 578.54 881.07 406.15
Days of Inventory on Hand
361.93 416.32 435.34 413.46 344.75 321.06 359.69 331.19 469.96 413.06
Average Receivables
56.88 47.55 36.09 29.34 26.91 23.06 18.76 22.89 19.03 8.04
Average Payables
27.91 16.39 14.69 9.44 8.73 9.05 7.90 8.42 5.43 1.81
Average Inventory
12.64 10.07 6.92 5.54 4.95 5.17 5.08 4.65 3.45 2.01
Average Assets
838.60 731.04 602.47 503.59 497.74 492.02 362.00 266.12 144.65 60.33
Average Common Equity
663.70 593.15 504.27 438.82 449.57 447.26 323.53 233.43 116.17 29.94

Fold the line items

Columns are period end dates